Insufficient scRNA-seq data for expression of CYP3A7 at single-cell level.
Insufficient scRNA-seq data for expression of CYP3A7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1074.90 | 226 / 226 | 80% | 29.50 | 323 / 406 |
kidney | 94% | 30.01 | 84 / 89 | 12% | 0.39 | 110 / 901 |
lung | 95% | 31.78 | 548 / 578 | 1% | 0.02 | 15 / 1155 |
breast | 82% | 90.96 | 378 / 459 | 1% | 0.01 | 6 / 1118 |
adrenal gland | 73% | 19.67 | 188 / 258 | 7% | 0.31 | 15 / 230 |
prostate | 72% | 13.35 | 176 / 245 | 1% | 0.01 | 4 / 502 |
pancreas | 64% | 8.41 | 210 / 328 | 2% | 0.02 | 3 / 178 |
intestine | 61% | 7.43 | 594 / 966 | 1% | 0.03 | 7 / 527 |
skin | 59% | 5.44 | 1069 / 1809 | 1% | 0.02 | 4 / 472 |
bladder | 52% | 2.57 | 11 / 21 | 5% | 0.21 | 23 / 504 |
ovary | 51% | 7.52 | 92 / 180 | 0% | 0 | 0 / 430 |
uterus | 49% | 19.03 | 83 / 170 | 1% | 0.01 | 4 / 459 |
esophagus | 45% | 5.06 | 656 / 1445 | 1% | 0.15 | 2 / 183 |
stomach | 33% | 2.07 | 120 / 359 | 1% | 0.04 | 4 / 286 |
adipose | 31% | 3.89 | 372 / 1204 | 0% | 0 | 0 / 0 |
thymus | 24% | 1.65 | 159 / 653 | 0% | 0.00 | 1 / 605 |
blood vessel | 20% | 1.16 | 270 / 1335 | 0% | 0 | 0 / 0 |
heart | 18% | 0.95 | 152 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 12% | 1.20 | 114 / 929 | 0% | 0 | 0 / 0 |
brain | 11% | 0.54 | 282 / 2642 | 0% | 0.00 | 1 / 705 |
spleen | 8% | 0.61 | 19 / 241 | 0% | 0 | 0 / 0 |
muscle | 5% | 0.20 | 39 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0006694 | Biological process | steroid biosynthetic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0002933 | Biological process | lipid hydroxylation |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0070989 | Biological process | oxidative demethylation |
GO_0008202 | Biological process | steroid metabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0070330 | Molecular function | aromatase activity |
GO_0062183 | Molecular function | all-trans retinoic acid 18-hydroxylase activity |
GO_0101020 | Molecular function | estrogen 16-alpha-hydroxylase activity |
GO_0019825 | Molecular function | oxygen binding |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0008401 | Molecular function | retinoic acid 4-hydroxylase activity |
GO_0020037 | Molecular function | heme binding |
GO_0050649 | Molecular function | testosterone 6-beta-hydroxylase activity |
GO_0008395 | Molecular function | steroid hydroxylase activity |
GO_0101021 | Molecular function | estrogen 2-hydroxylase activity |
Gene name | CYP3A7 |
Protein name | Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2) Cytochrome P450 variant 3A7 |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of steroid hormones and vitamins during embryogenesis . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) . Catalyzes the hydroxylation of carbon-hydrogen bonds. Metabolizes 3beta-hydroxyandrost-5-en-17-one (dehydroepiandrosterone, DHEA), a precursor in the biosynthesis of androgen and estrogen steroid hormones . Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1), particularly D-ring hydroxylated estrone at the C16-alpha position . Mainly hydroxylates all trans-retinoic acid (atRA) to 4-hydroxyretinoate and may play a role in atRA clearance during fetal development . Also involved in the oxidative metabolism of xenobiotics including anticonvulsants . . |
Accessions | Q6KGV3 P24462 ENST00000336374.4 [P24462-1] |